Legal Representation
Attorney
John Pickerill
USPTO Deadlines
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 26, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 26, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 10, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 10, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 4, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 7, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 7, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 7, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 7, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 7, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 5, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 5, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 5, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 5, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 7, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 7, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 7, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 4, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 1, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 7, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 25, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 25, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 25, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 29, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 2, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes in the nature of surgical dyes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy; dyes for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy in the nature of surgical dyes
Class 010
Medical devices for use in chromoendoscopy and endoscopy procedures of the gastrointestinal tract; medical devices to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; medical instruments to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; medical devices for enhancing visualization during chromoendoscopy, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy procedures; medical devices for introducing compositions containing dye into the human body for pharmaceutical, medical, surgical and medical diagnostic purposes; medical devices made with dye for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions for pharmaceutical, medical, surgical and medical diagnostic purposes
Additional Information
Design Mark
The mark consists of the term "VUEBLUE" in dark blue with the "V" and "B" capitalized surrounded by four blue and two additional intersecting curved lines, the last two of which vary in color from yellow to orange. The color white represents background and is not a claimed feature of the mark.
Color Claim
The color(s) blue, orange and yellow is/are claimed as a feature of the mark.
Classification
International Classes
005
010